Skip to main content

Table 2 NMAE and NRMSE of dose-rate in lesions and healthy livers across 6 test virtual patients, using our framework, and MC and DVK voxel-dosimetry methods

From: 90Y SPECT scatter estimation and voxel dosimetry in radioembolization using a unified deep learning framework

 

NMAE (%)

NRMSE (%)

SPECT w/CNN SC + DblurDoseNet

SPECT w/CNN SC + DVK

SPECT w/CNN SC + MC Dose

SPECT w/CNN SC + DblurDoseNet

SPECT w/CNN SC + DVK

SPECT w/CNN SC + MC Dose

Virtual patient #I

      

Lesion I (932.1 mL)

6.2

18.3

18.3

27.5

26.3

26.3

Lesion 2 (41.8 mL)

3.0

24.1

24.0

22.3

28.7

28.6

Healthy liver

4.1

18.5

18.4

33.6

36.7

36.7

Virtual patient #2

      

Lesion I (183.8 mL)

12.2

24.9

24.8

21.4

28.6

28.5

Healthy liver

0.7

17.0

17.0

28.5

30.8

30.8

Virtual patient #3

      

Lesion I (56.9 mL)

6.5

21.0

21.0

12.7

22.4

22.3

Healthy liver

5.1

17.5

17.5

23.5

25.8

25.8

Virtual patient #4

      

Lesion I (29.6 mL)

12.4

17.6

17.5

25.3

23.1

23.1

Lesion 2 (27.4 mL)

7.3

26.2

26.2

18.1

28.2

28.2

Lesion 3 (21.0 mL)

10.5

31.6

31.6

17.6

34.4

34.4

Lesion 4 (5.7 mL)

21.7

38.7

38.7

23.7

40.4

40.3

Healthy liver

1.7

16.6

16.6

23.6

24.6

24.6

Virtual patient #5

      

Lesion I (26.4 mL)

8.8

25.7

25.7

18.0

31.4

31.3

Healthy liver

14.2

21.4

21.6

24.0

27.7

27.7

Virtual patient #6

      

Lesion I (21.2 mL)

2.8

20.3

20.2

15.4

21.2

21.1

Lesion 2 (22.7 mL)

0.6

19.2

19.2

26.0

22.9

22.9

Lesion 3 (21.7 mL)

11.6

20.8

20.7

13.5

23.8

23.7

Healthy liver

6.5

16.3

16.4

25.0

24.2

24.1

  1. Mumbers in bold represent the best outcomes among the comparisons made within each table